{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:48:08Z","timestamp":1792594088083,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00105-022-04992-9","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T16:06:06Z","timestamp":1651075566000},"page":"442-451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Herpes zoster\u00a0\u2013 Pr\u00e4vention, Diagnostik und Behandlung","Herpes zoster\u2014prevention, diagnosis, and treatment"],"prefix":"10.1007","volume":"73","author":[{"given":"Ricardo Niklas","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Ghoreschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"issue":"1","key":"4992_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jdv.13995","volume":"31","author":"RN Werner","year":"2017","unstructured":"Werner\u00a0RN et al (2017) European consensus-based (S2k) Guideline on the Management of Herpes Zoster\u2014guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. J\u00a0Eur Acad Dermatol Venereol 31(1):9\u201319","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"4992_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/jdv.13957","volume":"31","author":"RN Werner","year":"2017","unstructured":"Werner\u00a0RN et al (2017) European consensus-based (S2k) Guideline on the Management of Herpes Zoster\u2014guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J\u00a0Eur Acad Dermatol Venereol 31(1):20\u201329","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"4992_CR3","first-page":"55","volume":"18","author":"GE Gross","year":"2020","unstructured":"Gross\u00a0GE et al (2020) S2k-Leitlinie zur Diagnostik und Therapie des Zoster und der Postzosterneuralgie. J\u00a0Dtsch Dermatol Ges 18(1):55\u201379","journal-title":"J Dtsch Dermatol Ges"},{"key":"4992_CR4","first-page":"541","volume":"50","author":"St\u00e4ndige Impfkommission (STIKO)","year":"2018","unstructured":"St\u00e4ndige Impfkommission (STIKO) (2018) Wissenschaftliche Begr\u00fcndung zur Empfehlung einer Impfung mit dem Herpes zoster-subunit-Totimpfstoff. Epid Bull 50:541\u2013567","journal-title":"Epid Bull"},{"key":"4992_CR5","first-page":"3","volume":"34","author":"St\u00e4ndige Impfkommission (STIKO)","year":"2021","unstructured":"St\u00e4ndige Impfkommission (STIKO) (2021) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut 2021. Epidemiol Bull 34:3\u201363","journal-title":"Epidemiol. Bull."},{"issue":"3","key":"4992_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","volume":"12","author":"L Zerboni","year":"2014","unstructured":"Zerboni\u00a0L et\u00a0al (2014) Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol 12(3):197\u2013210","journal-title":"Nat Rev Microbiol"},{"key":"4992_CR7","first-page":"1","volume":"p","author":"D Curran","year":"2021","unstructured":"Curran\u00a0D et al (2021) Meta-regression of herpes zoster incidence worldwide. Infect Dis Ther p:1\u201315","journal-title":"Infect Dis Ther"},{"issue":"Suppl 5","key":"4992_CR8","first-page":"25","volume":"19","author":"M Augustin","year":"2021","unstructured":"Augustin\u00a0M et al (2021) Inpatient care for skin diseases in Germany: multi-source analysis on the current and future health care needs. J\u00a0Dtsch Dermatol Ges 19(Suppl 5):25\u201353","journal-title":"J Dtsch Dermatol Ges"},{"key":"4992_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112300","author":"HC Ku","year":"2021","unstructured":"Ku HC et al (2021) Incidence of herpes zoster in HIV-infected patients undergoing antiretroviral therapy: a systematic review and meta-analysis. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm10112300","journal-title":"Clin Med"},{"issue":"4","key":"4992_CR10","doi-asserted-by":"publisher","first-page":"e13674","DOI":"10.1111\/tid.13674","volume":"23","author":"DE Kwon","year":"2021","unstructured":"Kwon\u00a0DE et al (2021) Incidence of herpes zoster in adult solid organ transplant recipients: a meta-analysis and comprehensive review. Transpl Infect Dis 23(4):e13674","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"4992_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/annrheumdis-2021-220651","volume":"81","author":"I Redeker","year":"2022","unstructured":"Redeker\u00a0I et\u00a0al (2022) Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register. Ann Rheum Dis 81(1):41\u201347","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4992_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jaad.2019.03.017","volume":"81","author":"E Baumrin","year":"2019","unstructured":"Baumrin\u00a0E et\u00a0al (2019) A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation. J\u00a0Am Acad Dermatol 81(1):102\u2013110","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"4992_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/annrheumdis-2021-220822","volume":"81","author":"KL Winthrop","year":"2022","unstructured":"Winthrop\u00a0KL et\u00a0al (2022) Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a\u00a0pooled analysis of six phase III clinical trials. Ann Rheum Dis 81(2):206\u2013213","journal-title":"Ann Rheum Dis"},{"key":"4992_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06096-0","author":"W Choi","year":"2022","unstructured":"Choi W et\u00a0al (2022) Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-022-06096-0","journal-title":"Clin Rheumatol"},{"key":"4992_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008858.pub4","author":"AM Gagliardi","year":"2019","unstructured":"Gagliardi\u00a0AM et\u00a0al (2019) Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008858.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"4992_CR16","unstructured":"GlaxoSmithKline GmbH & Co. KG. Fachinformation Shingrix, Stand September 2021. 2021."},{"issue":"40","key":"4992_CR17","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.1016\/j.vaccine.2020.07.049","volume":"38","author":"\u00c9 Racine","year":"2020","unstructured":"Racine \u00c9 et\u00a0al (2020) A systematic literature review of the recombinant subunit herpes zoster vaccine use in immunocompromised 18\u201349\u00a0year old patients. Vaccine 38(40):6205\u20136214","journal-title":"Vaccine"},{"issue":"1","key":"4992_CR18","doi-asserted-by":"publisher","first-page":"e52845","DOI":"10.1371\/journal.pone.0052845","volume":"8","author":"AK Sullivan","year":"2013","unstructured":"Sullivan\u00a0AK et al (2013) Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS ONE 8(1):e52845","journal-title":"PLoS ONE"},{"key":"4992_CR19","unstructured":"Raben D et\u00a0al (2012) HIV indicator conditions: guidance for implementing HIV testing in adults in health care settings. https:\/\/www.eurotest.org\/Portals\/0\/Documents\/Guidance.pdf.pdf?ver=2014-01-29-113626-000. Zugegriffen: 12. Jan. 2022"},{"issue":"51","key":"4992_CR20","doi-asserted-by":"publisher","first-page":"e9167","DOI":"10.1097\/MD.0000000000009167","volume":"96","author":"SL Wang","year":"2017","unstructured":"Wang\u00a0SL et al (2017) The efficacy of pregabalin for acute pain control in herpetic neuralgia patients: a meta-analysis. Medicine 96(51):e9167","journal-title":"Medicine"},{"key":"4992_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub4","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen\u00a0PJ et\u00a0al (2017) Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007938.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"4992_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jinf.2014.08.018","volume":"70","author":"K Hillebrand","year":"2015","unstructured":"Hillebrand\u00a0K et al (2015) Incidence of herpes zoster and its complications in Germany, 2005-2009. J\u00a0Infect 70(2):178\u2013186","journal-title":"J Infect"},{"issue":"1","key":"4992_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","volume":"157","author":"HJ Forbes","year":"2016","unstructured":"Forbes\u00a0HJ et al (2016) A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain 157(1):30\u201354","journal-title":"Pain"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-022-04992-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-022-04992-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-022-04992-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T13:10:34Z","timestamp":1654002634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-022-04992-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["4992"],"URL":"https:\/\/doi.org\/10.1007\/s00105-022-04992-9","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"assertion":[{"value":"29 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.N.\u00a0Werner und K.\u00a0Ghoreschi geben an, dass kein Interessenkonflikt besteht. RNW war in die Erstellung der europ\u00e4ischen und der deutschen Leitlinien zur Behandlung des Herpes zoster und der postherpetischen Neuralgie involviert.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}